Showing results (441-450 of 8,779) with videos related to
Sort By:
Pageof 878
Pediatric Blood & Cancer|August 29, 2025
Successful Use of Targeted HIF-2α Inhibition in EPAS1-Mutated Congenital ErythrocytosisElliot Ensink, Tobias Else, Mark Hannibal, et al.Pediatric Blood & Cancer|August 29, 2025
Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi-Institutional ExperienceAaron E Fan, Shaikha Alqahtani, Natalie Dailey Garnes, et al.Pediatric Blood & Cancer|September 1, 2025
Prevalence of Financial Hardship and Health-Related Social Needs in Pediatric Oncology: A Practice-Level Analysis of Systematic ScreeningMelissa P Beauchemin, Kathryn Henschel, David DeStephano, et al.Pediatric Blood & Cancer|September 1, 2025
Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long-Term Exposure While Maintaining EfficacyNatalia Wojciechowska, Alexandra E Richards, Aly Anthony, et al.Pediatric Blood & Cancer|August 30, 2025
Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource-Constrained Settings: A Cross-Sectional Study in LebanonMorgan Bou Zerdan, Adele Watfa, Bruna Kfoury, et al.Pediatric Blood & Cancer|May 22, 2021
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignanciesJenna Rossoff, David Jacobsohn, Soyang Kwon, et al.Pediatric Blood & Cancer|May 22, 2021
Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remissionJaume Mora, Alicia Castañeda, Maite Gorostegui, et al.Pediatric Blood & Cancer|May 18, 2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based studyMylene Bassal, Mariana Silva, Serina Patel, et al.Pediatric Blood & Cancer|August 14, 2021
Targeting plasma cells with daratumumab aids in the treatment of post-transplant autoimmune-like hepatitisRebecca Epperly, Teresa Santiago, Cara E Morin, et al.Pediatric Blood & Cancer|May 31, 2020
Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphomaHiroto Inaba, Olga Varechtchouk, Michael D Neel, et al.Pageof 878